Pds biotech announces conference call and webcast for first quarter 2025 financial results

Princeton, n.j., may 07, 2025 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb) (“pds biotech” or the “company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that the company will host a conference call to report financial results for the quarter ended march 31, 2025, and provide a clinical programs update on wednesday, may 14, 2025 at 8:00 a.m.
PDSB Ratings Summary
PDSB Quant Ranking